Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
14.75
-0.36 (-2.38%)
At close: Jul 17, 2026, 4:00 PM EDT
14.69
-0.06 (-0.41%)
After-hours: Jul 17, 2026, 4:24 PM EDT
Crescent Biopharma Employees
Crescent Biopharma had 55 employees as of March 31, 2026. The number of employees increased by 11 or 25.00% since the number was last reported on December 31, 2025.
Employees
55
Change
11
Growth
25.00%
Revenue / Employee
$216,055
Profits / Employee
-$2,946,855
Market Cap
490.13M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 55 | 11 | 25.00% |
| Dec 31, 2025 | 44 | 38 | 633.33% |
| Dec 31, 2024 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Ginkgo Bioworks Holdings | 485 |
| Arvinas | 246 |
| ProKidney | 231 |
| Verastem | 102 |
| Silence Therapeutics | 88 |
| Assembly Biosciences | 73 |
| Contineum Therapeutics | 51 |
CBIO News
- 1 day ago - Crescent Biopharma Announces Closing of Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 3 days ago - Crescent Biopharma 8.095M share Spot Secondary priced at $14.50 - TheFly
- 3 days ago - Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants - GlobeNewsWire
- 3 days ago - Crescent Biopharma files ordinary shares offering, no amount given - TheFly
- 3 days ago - Crescent Biopharma Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants - GlobeNewsWire
- 16 days ago - Crescent Biopharma Registration statement: Registration filing - Filings
- 21 days ago - Crescent Biopharma Announces Grants of Inducement Awards - GlobeNewsWire
- 5 weeks ago - Crescent Biopharma Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts